Facts
as of Nov 16, 2026
Neurocrine Biosciences is a biopharmaceutical company headquartered in San Diego, California, that discovers, develops and commercializes treatments for neurological, psychiatric, endocrine and immunological disorders. Founded in 1992 and listed on Nasdaq, it markets medicines for tardive dyskinesia, Huntington's disease chorea and classic congenital adrenal hyperplasia, partners with AbbVie on endometriosis and uterine fibroid therapies, and runs several late-stage programs. Most openings are at the San Diego headquarters in manufacturing, quality, analytical development, regulatory strategy and IT, alongside field roles such as NeuroPsych account specialists and medical science liaisons.
It is hiring: 78 open roles, 26 of them posted in the last 30 days. Its stated pay is 19% above the market estimate for the same roles.
- Headquarters
- San Diego, United States
- Founded
- 1992
- Employees
- 1001-5000estimated range
- Revenue
- $2.9B2025 · SEC
- Listing
- NASDAQ: NBIX
- Open roles
- 78 in 4 citiesAlion job postings
- Website
- neurocrine.com
As of Nov 16, 2026, Alion lists 78 open roles at Neurocrine Biosciences. Neurocrine Biosciences is headquartered in San Diego, United States. It was founded in 1992. The median pay stated in its open roles is $223k, across 64 postings that state pay.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Postings are real
Alion truth index: B
83/100
Ghost roles
re-checked against its careers site
0%
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Domain and mail securityneurocrine.com · Nov 16, 2026
Spoofed mail (DMARC)
Spoofed mail goes to spam
Good
Who may send its mail (SPF)
Other senders soft-fail (~all)
Good
HTTPS certificate
Valid certificate · Let's Encrypt
Good
HTTPS enforced (HSTS)
Enforced
Good
Security contact (security.txt)
No security.txt
Weak
Encrypted mail delivery (MTA-STS)
No MTA-STS policy
Weak
Signed DNS (DNSSEC)
Not signed
Weak
Certificate issuers (CAA)
Any authority may issue certificates
Weak
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices The domain: its DNS records, its site's headers and certificate.
Hiring steadily, with new roles every week.
Science & Research is the largest family, 29 of open roles.
26Posted in 30 days33% of open roles are fresh
38%Remote roles30 of 79
1Roles in AI1% of open roles
4Hiring offices
Can they hire you from United States?by your location
Likely
150 open roles are in your country: you apply locally, no move needed.
United States150On site
Switzerland4On site
United Kingdom2On site
Remote, from elsewhere30Possible
No posting offers visa sponsorship. Remote roles: 30.
Time to fillmedian days to close a role
Neurocrine Biosciences32 days
Market, same roles30 days
Alion signals0-100
Demand95
Pay60
Your chance52
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 28This week
Open roles a week: 151 then, 0 now
Are the postings real?
B
83 / 100Neurocrine Biosciences scores B on the Alion truth index (A is best, E worst), measured over 6 open roles re-checked against its own hiring board: 0% look like ghost listings, 67% have gone stale and 0% are the same role posted again. Its roles close in a median of 37 days.
Ghost roles0%
Gone stale67%
Reposted0%
Where the openings areshare of open roles · trend
Science & Research29
Biotech19▼
Analytics8
Legal6▼
Management5▲
Operations5▲
What postings ask forlanguages named in open roles
Degree asked
Bachelor's Degree 52%Doctoral Degree (PhD) 24%Master's Degree 15%High School Diploma 9%
Experience asked: 8.4 years on average, in 72 postings. 66 postings state a degree.
Benefits named in postingsshare of open roles
Equity7292%
Retirement plans7292%
Continuous learning23%
Professional development11%
Growth opportunities11%
Home office11%
Contract type
Full-Time 76Contract 1
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Pays 19% above the market estimate for the same roles.
$231kMedianmarket estimate $184k
$179k – $257kTypical rangeUSD a year
$452kHighest paying roleExecutive Director, Clinical Development – Immunology (MD)
Pay by levelmiddle half of stated pay, median marked · dashed: market median $184k
Senior29$196k$179k – $231k
Lead6$214k$182k – $214k
Head+21$265k$238k – $348k
$0$100k$200k$300k$400k
Source: the pay stated in the company's postings, normalised to USD a year
Named in the work visa registers of United States.
18 ▲ 80%H-1B filings in 12 months
$123kMedian offered salary
72Open roles in United States
In the register as Neurocrine Biosciences, Inc., San Diego, CA (+1 more)
Other sponsors in the same field
US Department of Labor · latest filing Jun 25, 2026
Footprint
Hiring in 4 cities in 3 countries.
4Cities
3Countries
San DiegoBusiest site
Source: office addresses in postings and company registers
Ranked #7 by open roles among its 11 closest peers.
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)
Financials
Revenue of $2.9B in 2025. +21.4% on the year before. Net income $478.6M.
$2.9BRevenue2025 · +21.4%
$478.6MNet income2025 · +40.2%
Revenue by yearas filed, with the net income
2025$2.9Bnet income $478.6M
2024$2.4Bnet income $341.3M
2023$1.9Bnet income $249.7M
2022$1.5Bnet income $154.5M
2021$1.1Bnet income $89.6M
2020$1Bnet income $407.3M
2019$788.1Mnet income $37M
2018$451.2Mnet income $21.1M
Sources: SEC
Technologies named in job postings at Neurocrine Biosciences over the last 12 months, by layer, with the share of postings for each.
64Technologies in use
87Postings analysed
65/100Stack modernityAI adopter
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Milestones
Each milestone is dated by its source: registers, filings, the press
Newsroom
Sep 292026
News · MM+M - Medical Marketing and Media
Spectrum Science previously provided PR support to Neurocrine.
Sep 292026
News · RTTNews
Neurocrine Biosciences, Inc. (NBIX) announced that Eiry W. Roberts will return as Chief Medical Officer, effective immediately, succeeding Sanjay Keswani, who will depart the com…
Sep 282026
News · YahooFinance
Neurocrine Biosciences (NBIX) said late Monday that Eiry Roberts will rejoin the company
Sep 282026
News · YahooFinance
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Eiry W. Roberts, M.D., who previously served as Neurocrine
Sep 282026
News · marketscreener.com
Sources: the outlets named on each headline, each story once